Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,421 | -129 | -85 | -27 | -141 |
| Depreciation Amortization | 123 | N/A | N/A | N/A | N/A |
| Accounts receivable | -534 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | -24 | N/A | N/A | N/A |
| Other Working Capital | 159 | -24 | -25 | -40 | 0 |
| Other Operating Activity | 924 | 24 | 0 | 0 | 4 |
| Operating Cash Flow | $-1,749 | $-153 | $-110 | $-66 | $-137 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 552 | 552 | N/A | -552 |
| PPE Investments | -1,291 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -45 | 0 | 0 | 0 | 61 |
| Investing Cash Flow | $-1,336 | $552 | $552 | $N/A | $-492 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 800 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 2,546 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -45 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $3,301 | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 1,261 | 180 | 180 | 180 | 808 |
| End Cash Position | 1,477 | 579 | 622 | 113 | 180 |
| Net Cash Flow | $216 | $400 | $443 | $-66 | $-628 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,749 | -153 | -110 | -66 | -137 |
| Capital Expenditure | -1,291 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -3,040 | -153 | -110 | -66 | -137 |